Rochester, MN, United States of America

Troy R Wegman

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Mayo Foundation for Medical Education and Research. Active years: 2010.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2010

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Troy R Wegman

Introduction

Troy R Wegman is an accomplished inventor based in Rochester, MN (US). He has made significant contributions to the field of medical research, particularly in the area of virology. His work has led to the development of innovative methods and materials that are crucial for obtaining Paramyxoviridae virus preparations.

Latest Patents

Troy R Wegman holds one patent related to his research. The patent focuses on Paramyxoviridae virus preparations, detailing methods and materials that enhance the process of obtaining these virus preparations. This innovation is vital for advancing medical research and potential treatments.

Career Highlights

Wegman is associated with the Mayo Foundation for Medical Education and Research, a leading institution in medical research and education. His role at this prestigious organization has allowed him to contribute to groundbreaking research and innovations in the medical field.

Collaborations

Throughout his career, Troy R Wegman has collaborated with notable colleagues, including Mark J Federspiel and Kirsten K Langfield. These collaborations have fostered a productive environment for research and innovation.

Conclusion

Troy R Wegman's contributions to the field of virology through his patent and work at the Mayo Foundation for Medical Education and Research highlight his dedication to advancing medical science. His innovative approaches continue to impact the research community positively.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…